European Journal of Pediatrics

, Volume 170, Issue 7, pp 845–850

Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents

  • Paola Giordano
  • Giovanni Carlo Del Vecchio
  • Valerio Cecinati
  • Maurizio Delvecchio
  • Maria Altomare
  • Fabrizia De Palma
  • Domenico De Mattia
  • Luciano Cavallo
  • Maria Felicia Faienza
Original Paper


Childhood obesity and its related comorbidities are increasingly recognised in children, predisposing them to early cardiovascular disease and metabolic syndrome. The objective of the study was to investigate markers of metabolism, inflammation and haemostasis in a group of Italian obese children and adolescents. Fifty-nine obese and 40 non-obese subjects were recruited. Fasting glucose and insulin, total cholesterol, HDL and LDL cholesterol, triglycerides, high-sensitivity C-reactive protein (hsCRP), tumour necrosis factor alpha (TNF-α), and adiponectin were measured. Hypercoagulability was assessed by measuring the circulating levels of thrombin-antithrombin complex (TAT), D-dimer, fibrinogen, plasminogen activator inhibitor 1 (PAI-1) and von Willebrand Factor (vWF). A significant degree of insulin resistance was present in obese subjects compared with controls (p < 0.0001). The obese showed higher levels of total cholesterol, LDL cholesterol and triglycerides, and lower levels of HDL cholesterol than controls (p < 0.0001). Circulating levels of hsCRP and TNF-α were significantly higher in obese than in controls while serum adiponectin levels were significantly lower in obese than non-obese subjects (p < 0.001; p = 0.031; p < 0.0001, respectively). vWF, TAT, D-dimer, fibrinogen and PAI-1 levels were significant higher in obese subjects compared with control group (p = 0.02; p < 0.0001; p = 0.0037; p < 0.0001; p = 0.017, respectively). In conclusion, our results suggest that childhood obesity per se is associated with a proinflammatory and prothrombotic state.


Childhood obesity High-sensitivity C-reactive protein (hsCRP) Tumour necrosis factor alpha Thrombin-antithrombin complex (TAT) Plasminogen activator inhibitor 1 (PAI-1) von Willebrand Factor (vWF) 


  1. 1.
    Am C, Caprio S (2008) Obesity in children and adolescents. J Clin Endocrinol Metab 93:S31–S36CrossRefGoogle Scholar
  2. 2.
    Atabek ME (2008) Relationship between endothelial dysfunction, carotid artery intima media thickness and circulating markers of vascular inflammation in obese hypertensive children and adolescents. J Pediatr Endocrinol Metab 21:603–604PubMedGoogle Scholar
  3. 3.
    Caballero AE, Bousquet-Santos K, Robles-Osorio L et al (2008) Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance. Diab Care 31:576–582CrossRefGoogle Scholar
  4. 4.
    Cacciari E, Milani S, Balsamo A et al (2006) Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Investig 29:581–593Google Scholar
  5. 5.
    Cole TJ, Bellizzi MC, Flegal KM et al (2000) Establishing a standard definition for child overweight and obesity worldwide: International survey. Brit Med J 7244:1240–1243CrossRefGoogle Scholar
  6. 6.
    Cook JM, Semple RK (2010) Hypoadiponectinemia—cause or consequence of human “insulin resistance”? J Clin Endocrinol Metab 95:1544–1554PubMedCrossRefGoogle Scholar
  7. 7.
    Daniels SR (2006) The consequences of childhood overweight and obesity. Future Child 16:47–67PubMedCrossRefGoogle Scholar
  8. 8.
    Ferguson MA, Gutin B, Owens S et al (1999) Effect of physical training and its cessation on the hemostatic system of obese children. Am J Clin Nutr 69:1130–1134PubMedGoogle Scholar
  9. 9.
    Gallistl S, Sudi KM, Borkenstein M et al (2000) Correlation between cholesterol, soluble P-selectin, and D-dimer in obese children and adolescents. Blood Coagul Fibrinolysis 11:755–760PubMedCrossRefGoogle Scholar
  10. 10.
    Gilardini L, McTernan PG, Girola A et al (2006) Adiponectin is a candidate marker of metabolic sindrome in obese children and adolescents. Atherosclerosis 189:401–407PubMedCrossRefGoogle Scholar
  11. 11.
    Hotamisligil GS (2003) Inflammatory pathways and insulin action. Int J Obes 27:S53–S55CrossRefGoogle Scholar
  12. 12.
    Iñiguez G, Torrealba IM, Avila A et al (2008) Adiponectin serum levels and their relationships to androgen concentrations and ovarian volume during puberty in girls with type 1 diabetes mellitus. Horm Res 70:112–117PubMedCrossRefGoogle Scholar
  13. 13.
    Kato H, Kahiwagi H, Shiraga M et al (2006) Adiponectin acts as an endogenous antithrombotic factor. Arterioscler Thromb Vasc Biol 26:224–230PubMedCrossRefGoogle Scholar
  14. 14.
    Klein S, Burke LE, Bray GA, American Heart Association Council on Nutrition, Physical Activity, and Metabolism et al (2004) Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 110:2952–2967PubMedCrossRefGoogle Scholar
  15. 15.
    Martos R, Valle M, Morales RM et al (2009) Changes in body mass index are associated with changes in inflammatory and endothelial dysfunction biomarkers in obese prepubertal children after 9 months of body mass index SD score loss. Metabolism 58:1153–1160PubMedCrossRefGoogle Scholar
  16. 16.
    Masuccio FG, Lattanzio FM, Matera S et al (2009) Insulin sensitivity in prepubertal Caucasian normal weight children. J Clin Endocrinol Metab 22:695–702Google Scholar
  17. 17.
    Mauras N, Delgiorno C, Kollman C et al (2010) Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children. J Clin Endocrinol Metab 95:1060–1068PubMedCrossRefGoogle Scholar
  18. 18.
    Meigs JB, O’donnell CJ, Tofler GH et al (2006) Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes 55:530–537PubMedCrossRefGoogle Scholar
  19. 19.
    Ritchie SA, Connell JM (2007) The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 17:319–26PubMedCrossRefGoogle Scholar
  20. 20.
    Romano M, Guagnano MT, Pacini G (2003) Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women. J Clin Endocrinol Metab 88:5321–5326PubMedCrossRefGoogle Scholar
  21. 21.
    Tan KC, Xu A, Chow WS et al (2004) Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab 89:765–769PubMedCrossRefGoogle Scholar
  22. 22.
    Tanner JM, Whitehouse RH (1976) Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 51:170–179PubMedCrossRefGoogle Scholar
  23. 23.
    Tchernova J, Whincup P, Lowe GD et al (2009) Plasma leptin: associations with metabolic, inflammatory and hemostatic risk factors for cardiovascular disease. Atherosclerosis 191:418–426Google Scholar
  24. 24.
    Valle Jiménez M, Estepa RM, Camacho RM et al (2007) Endothelial dysfunction is related to insulin resistance and inflammatory biomarker levels in obese prepubertal children. Eur J Endocrinol 156:497–502PubMedCrossRefGoogle Scholar
  25. 25.
    Valle M, Martos R, Gascon F et al (2005) Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diab Metab 31:55–62CrossRefGoogle Scholar
  26. 26.
    Weiss R, Dziura J, Burgert TS et al (2004) Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362–2374PubMedCrossRefGoogle Scholar
  27. 27.
    Williams CL, Hayman LL, Daniels SR et al (2002) Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 106:143–160PubMedCrossRefGoogle Scholar
  28. 28.
    World Health Organization Department of Non communicable Disease Surveillance (1999). Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation, Geneva, World Health OrganizationGoogle Scholar
  29. 29.
    Wozniak SE, Gee LL, Wachtel MS et al (2009) Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci 54:1847–1856PubMedCrossRefGoogle Scholar
  30. 30.
    Yamamoto K, Takeshita K, Tetsuhito K et al (2005) Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in elderly. Cardiovasc Res 66:276–285PubMedCrossRefGoogle Scholar
  31. 31.
    Yasar S, Nurgun K, Ayfer A et al (2008) Prevalence and risk factors of metabolic syndrome in obese children and adolescents: the role of the severity of obesity. Eur J Pediatr 167:1183–1189CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Paola Giordano
    • 1
  • Giovanni Carlo Del Vecchio
    • 1
  • Valerio Cecinati
    • 1
  • Maurizio Delvecchio
    • 1
  • Maria Altomare
    • 1
  • Fabrizia De Palma
    • 1
  • Domenico De Mattia
    • 1
  • Luciano Cavallo
    • 1
  • Maria Felicia Faienza
    • 1
  1. 1.Department of Biomedicine of Developing AgeUniversity of BariBariItaly

Personalised recommendations